
Vascular Discovery Scientific Sessions - American Heart Association 2027
Event Date
July 22–25, 2027
Location
Boston, MA
About This Show
AI-drafted summaryVascular Discovery: From Genes to Medicine Scientific Sessions is the American Heart Association's annual meeting dedicated to translational and basic science in cardiovascular and vascular disease. The meeting offers a dynamic and immersive experience for those advancing translational science and research in cardiovascular and vascular diseases, featuring plenary lectures, award competitions, poster sessions, and targeted concurrent sessions.
The program draws clinicians, physician-scientists, basic researchers, and early-career investigators and trainees. It explores timely topics including thrombosis, hemostasis and lymphatic biology; peripheral artery disease and cerebrovascular disease; immunology and inflammation; metabolic disorders and smooth muscle cell dysfunction; lipid metabolism and novel therapeutics; and genomics, epigenetics and precision medicine.
From early career training and mentorship events to high-impact presentations by leading investigators, the meeting is an opportunity to engage with the latest advances, connect with peers, and shape the future of cardiovascular translational research. A notable change for 2027 is co-location: the American Heart Association will co-locate the Vascular Discovery and BCVS (Basic Cardiovascular Sciences) Scientific Sessions meetings in Boston, running the two consecutively.
Show Highlights
Signature features of the meeting include:
- Plenary and keynote lectures from leading investigators in vascular biology and cardiovascular medicine.
- Award competitions and named lectures, including the Jeffrey M. Hoeg Arteriosclerosis, Thrombosis, and Vascular Biology Award and the PVD Mid-Career Award and Lecture.
- Poster sessions and ePosters showcasing the latest translational and basic research.
- Early-career training and mentorship events aimed at trainees and junior investigators.
- New for 2027: Vascular Discovery is co-located and run consecutively with the BCVS (Basic Cardiovascular Sciences) Scientific Sessions in Boston, helping attendees experience both meetings.
Recent marquee speakers have included prominent figures in the field. At the 2026 edition, Peter Libby, MD, FAHA, of Harvard Medical School and Brigham and Women's Hospital served as Keynote Lecturer, and he is a globally recognized leader known for his research on inflammation and atherosclerosis. Kiran Musunuru, MD, PhD, of the University of Pennsylvania delivered the Vascular Discovery Distinguished Lecture and is an internationally recognized leader in cardiovascular genetics and gene editing.
Registration
Registration is handled through the American Heart Association. For the 2027 meeting, registration is scheduled to open in Winter 2026, with abstracts opening in Autumn 2026.
AHA members typically receive discounted registration rates, and becoming a member before registering can reduce costs. Registration questions can be directed to the AHA registration team by phone at 1-508-743-8517, Monday through Friday, 9 a.m. to 5 p.m. ET. Note that co-located meetings such as BCVS and any affiliated conferences may require separate registration.
History
Vascular Discovery: From Genes to Medicine Scientific Sessions is presented by the American Heart Association and evolved from the AHA's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) and Peripheral Vascular Disease (PVD) scientific programming. The meeting brings together the vascular biology community around basic and translational research each year in rotating U.S. cities. The 2026 edition was held May 13–16, 2026, at the Hyatt Regency Bellevue in Bellevue, Washington. A milestone for 2027 is the decision by the American Heart Association to co-locate the Vascular Discovery and BCVS Scientific Sessions in Boston, running them consecutively.
Frequently Asked Questions
When and where is Vascular Discovery 2027 taking place?
Vascular Discovery: From Genes to Medicine Scientific Sessions will be held July 22–25, 2027, at The Westin Boston Seaport District in Boston, Massachusetts.
Who should attend the meeting?
The meeting is designed for clinicians, physician-scientists, basic and translational researchers, and early-career investigators and trainees working in cardiovascular and vascular disease. It emphasizes translational science, mentorship, and networking across the vascular biology community.
What topics does the program cover?
The program covers thrombosis, hemostasis and lymphatic biology; peripheral artery disease and cerebrovascular disease; immunology and inflammation; metabolic disorders and smooth muscle cell dysfunction; lipid metabolism and novel therapeutics; and genomics, epigenetics and precision medicine.
How and when can I register?
Registration is handled by the American Heart Association and is scheduled to open in Winter 2026, with abstract submission opening in Autumn 2026. AHA members generally receive discounted registration rates.
What is new about the 2027 edition?
For 2027, the American Heart Association is co-locating Vascular Discovery and the BCVS (Basic Cardiovascular Sciences) Scientific Sessions in Boston, running the two meetings consecutively so attendees can benefit from both.
From the blog
Recent guides and industry insights for exhibitors and planners.








